The Use of Complementary and Alternative Therapies by the Families of Children with Chronic Conditions and Disabilities

Infants and Young Children

Volumn 14, Issue 1, 2001, Pages 67-78

  Nickel, Robert E ^a,b   Gerlach, Elizabeth King ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE

Author keywords

Attention deficit hyperactivity disorder; Cerebral palsy; Complementary and alternative therapies; Health care decision making; Risk communication

Indexed keywords

EID: 0346977975     PISSN: 08963746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001163-200114010-00009     Document Type: Article

References (65)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends In alternative medicine use in the United States, 1990-1997. JAMA. 1998;280(18):1569-1575.
2. Norred CL, Zamudio S, Palmer SK. Use of complementary and alternative medicines by surgical patients. AANA J. 2000;68(1):13-18.
3. Perlman Al, Eisenberg DM, Panush RS. Talking with patients about alternative and complementary medicine. Pheum Dis Clin North Am. 1999;25(4):815-822.
4. Grootenhuis MA, Last BF, de Graaf-Nijkerk JH, van der Wel M. Use of alternative treatment in pediatric oncology. Cancer Nurs. 1998;21(4):282-288.
5. Fernandez CV, Stutzer CA, MacWilliam L, Fryer C Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse. J Clin Oncol. 1998;16(4):1279-1286.
6. Nickel RE. Controversial therapies for young children with developmental disabilities. Inf Young Child. 1996;8(4):29-40.
7. Stubberfield TG, Wray JA, Parry TS. Utilization of alternative therapies in attention-deficit hyperactivity disorder. J Paediatr Child Health. 1999;35:450-453.
8. National Institutes of Health, National Center for Complementary and Alternative Medicine Web site (2001). http://nccam.nih.gov/nccam/an/general/ index.html. Accessed on Feb. 1, 2001.
9. Wetzel MS, Eisenberg DM, Kaptchuk TJ. Courses involving complementary and alternative medicine at U.S. medical schools. JAMA. 1998;280(9):784-787.
10. Kemper KJ, Vincent EC, Scardapane JN. Teaching an integrated approach to complementary, alternative, and mainstream therapies for children: a curriculum evaluation. J Alternative Complementary Med. 1999;5(3):261-268.
11. Sikand A, Laken M. Pediatricians' experience with and attitudes toward complementary/alternative medicine. Arch Pediatr Adolesc Med. 1998;152(11):1059-1064.
12. Pelletier KR, Astin JA, Haskell WL. Current trends in the integration and reimbursement of complementary and alternative medicine by managed care organizations (MCOs) and insurance providers: 1998 update and cohort analysis. Am J Health Promotion. 1999;14(2):125-133.
13. Kemper KJ. Complementary and alternative medicine for children: does it work? Arch Dis Child. 2001;84:6-9.
14. Sackett DL. Evidence-based medicine. Semin Perinatol. 1997;21(1):3-5.
15. Law M. Strategies for implementing evidence-based practice in early intervention. Inf Young Child. 2000;13(2):32-40.
16. Baumgaertel A. Alternative and controversial treatments for attention-deficit/hyperactivity disorder. Pediatr Clin North Am. 1999;46(5):977-992.
17. Hyman SL, Levy SE. Autistic spectrum disorders: when traditional medicine is not enough. Contemp Pediatr. 2000;10:101-116.
18. Chan E, Gardiner P, Kemper KJ. "At least it's natural . . ." Herbs and dietary supplements in ADHD. Contemp Pediatr. 2000;17(9):116-130.
19. Bloom BS, Retbi A, Dahan S, Jonsson E. Evaluation of randomized controlled trials on complementary and alternative medicine. Int J Technol Assess Health Care. 2000;16:13-21.
20. Edwards A, Elwyn G. How should effectiveness of risk communication to aid patients' decisions be judged? A review of the literature. Med Decis Making. 1999;1900:428-434.
21. Hibbard JH, Solvic P, Jewett JJ. Informing consumer decisions in health care: implications from decision-making research. Milbank Q. 1997;75(3):395-415.
22. Slovic P. Perception of risk. Science. 1987;236:280-285.
23. Varley CK. Diet and behaviour of children with attention deficit disorder. J Am Acad Child Psychiatry. 1984;23:182-185.
24. Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med. 1999;61:712-728.
25. Heiligenstein E, Guenther G. Over-the-counter psychotropics: a review of melatonin, St. John's wort, valerian, and kava-kava. J of Am Col Health. 1998;46:271-276.
26. Johns Cupp M. Herbal remedies: adverse effects and drug interactions. Am Fam Physician. 1999;59(5):1239-1244.
27. Wender EH. The food additive-free diet in the treatment of behavior disorders: a review. J Dev Behav Pediatr. 1986;7(1):35-42.
28. Williams JI, Cram DM, Tausig FT, Webster E. Relative effects of drugs and diet on hyperactive behaviors: an experimental study. Pediatrics. 1978;61(6):811-817.
29. Swanson JM, Kinsbourne M. Food dyes impair performance of hyperactive children on a laboratory learning test. Science. 1980;207(4438):1485-1487.
30. Harley JP, Ray RS, Tomasi L, et al. Hyperkinesis and food additives: testing the Feingold hypothesis. Pediatrics. 1978;61(6):818-828.
31. Levy F, Dumbrell S, Hobbes G, Ryan M, Wilton N, Woodhill JM. Hyperkinesis and diet: a double-blind crossover trial with a tartrazine challenge. Med J Aust. 1978;1(2):61-64.
32. Rowe KS. Synthetic food colourings and "hyperactivity": a double-blind crossover study. Aust Paediatr J. 1988;24(2):143-147.
33. Boris M, Mandel FS. Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy. 1994;72(5):462-468.
34. Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A metaanalysis. JAMA. 1995;274(20):1617-1621.
35. Hughes JR, Hale KL Behavioral effects of caffeine and other methylxanthines on children. Exp Clin Psychopharmacol. 1998;6(1):87-95.
36. Stein MA, Krasowski M, Leventhal BL, Phillips W, Bender BG. Behavioral and cognitive effects of methylxanthines. A meta-analysis of theophylline and caffeine. Arch Pediatr Adolesc Med. 1996;150(3):284-288.
37. Aman MG, Mitchell EA, Turbott SH, et al. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychot. 1987;15:75-90.
38. Arnold LE, Kleykamp D, Votolato NA, et al. Gamma-linolenic acid for attention-deficit hyperativity disorder: placebo-controlled comparison to D-amphetamine. Biol Psychiatry. 1989;25:222-228.
39. American Botanical Council. How to find reliable herbs. Health. March 1999;99.
40. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginko biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55:1409-1415.
41. Upledger JE. An overview of craniosacial therapy: its origin and its applications for newborns and infants. Inf Young Child. 1996;9(2):59-68.
42. Upledger Institute. Therapeutic benefits of: craniosacral therapy (2001). http://www.upledger.com/ therben.htm. Accessed on Feb. 1, 2001.
43. Hanten WP, Dawson DD, Iwata M, Seiden M, Whitten FG, Zink T. Craniosacral rhythm: reliability and relationships with cardiac and respiratory rates. J Orthop Sports Phys Ther. 1998;27(3):213-218.
44. Rogers JS, Witt PL, Gross MT, Hacke JD, Genova PA. Simultaneous palpation of the craniosacral rate at the head and feet: intrarater and interrater reliability and rate comparisons. Phys Ther. 1998;78(11):1175-1185.
45. Wirth-Pattullo V, Hayes KW. Interrater reliability of craniosacral rate measurements and their relationship with subjects' and examiners' heart and respiratory rate measurements. Phys Ther. 1994;74(10):908-916; discussion 917-920.
46. Green C, Martin CW, Bassett K, Kazanjian A. A systematic review of craniosacral therapy: biological plausibility, assessment reliability and clinical effectiveness. Complementary Ther Med. 1999;7(4):201-207.
47. Greenman PE, McPartland JM. Cranial findings and iatrogenesis from craniosacral manipulation in patients with traumatic brain syndrome. J Am Osteopath Assoc. 1995;95(3):182-188.
48. Pape KE. Therapeutic electrical stimulation: the past, the present, the future. NDTA Network. July/August 1996;1-7.
49. Pape KE, Kirsch SE, Galil A, Boulton JE, White MA, Chipman M. Neuromuscular approach to the motor deficits of cerebral palsy: a pilot study. J Pediatr Orthop. 1993;13(5):628-633.
50. Pape KE, Kirsch SE. Technology-assisted self care in the treatment of spastic diplegia. In: Sussman M, ed. Diplegic Child. Park Ridge, IL: Academy of Orthopedic Surgeons; 1992:241-251.
51. Barry MJ. Physical therapy interventions for patients with movement disorders due to cerebral palsy. J Child Neurol. 1996;11(S1):S51-S60.
52. Steinbok P, Reiner A, Kestle JR. Therapeutic electrical stimulation following selective posterior rhizotomy In children with spastic diplegic cerebral palsy: a randomized clinical trial. Dev Med Child Neurol. 1997;39(8):515-520.
53. The Center for Functional Restoration Web site, http:/ /nyneurosurgery.org/cfr/child/spastlcity/tes/ tes_int-html. Accessed on Feb. 1, 2001.
54. Rockswold GL, Ford SE, Anderson DC, Bergman TA, Sherman RE. Results of a prospective randomized trial for treatment of severely brain-injured patients with hyperbaric oxygen. J Neurosurg. 1992;76(6):929-934.
55. Nighoghossian N, Trouillas P, Adeleine P, Salord F. Hyperbaric oxygen in the treatment of acute ischemic stroke. A double-blind pilot study. Stroke. 1993;26(8):1369-1372.
56. Kleijnen J, Knipschild P. Hyperbaric oxygen for multiple sclerosis. Review of controlled trials. Acta Neurol Scand. 1995;91(5):330-334.
57. Packard M. The Cornell Study. Review of paper presented at the University of Graz (November 18, 2000). http://www.hot4rcpkidsfoundation.on.ca/ main1.html. Accessed on Feb. 1, 2001.
58. Montgomery D, Goldberg J, Amar M. Effects of hyperbaric oxygen therapy on children with spastic diplegic cerebral palsy: a pilot project. Undersea Hyperbaric Med. 1999;26(4):235-242.
59. Collet JP, Vanasse M. Multicenter, double-blind placebo controlled randomized clinical trial to assess efficacy of hyperbaric oxygen in children with cerebral palsy. Presented at the annual meeting of the American Academy for Cerebral Palsy and Developmental Medicine; September 2000; Toronto, Canada.
60. Sheffield PJ, Desautels DA. Hyperbaric and hypobaric chamber fires: a 73-year analysis. Undersea Hyperbaric Med. 1997;24(3):153-164.
61. Gerlach EK. Autism Treatment Guide. 2nd ed. Arlington, TX: Future Horizons; 2000.
62. Backman CL, Harris SR. Case studies, single-subject research, and N of 1 randomized trials: comparisons and contrasts. Am J Phys Med Rehabil. 1999;78(2):170-176.
63. Backman CL, Harris SR, Chisholm JA, Monett AD. Single-subject research in rehabilitation: a review of studies using AB, withdrawal, multiple baseline, and alternating treatments designs. Arch Phys Med Rehabil. 1997;78(10):1145-1153.
64. Nikles CJ, Glasziou PP, Del Mar CB, Duggan CM, Clavarino A, Yelland MJ. Preliminary experiences with a single-patient trials service in general practice. Med J Aust. 2000;173(2):100-103.
65. Kanning M. Why I would want to use complementary and alternative therapy: a patient's perspective. Rheum Dis Clin North Am. 1999;25(4):823-831.